Alkeon Capital Management LLC Trims Position in BioCryst Pharmaceuticals, Inc. $BCRX

Alkeon Capital Management LLC decreased its position in BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) by 4.4% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 5,464,021 shares of the biotechnology company's stock after selling 250,000 shares during the quarter. Alkeon Capital Management LLC owned